The current body of research on Parkinson's disease (PD) screening, monitoring, and management has evolved along two largely independent trajectories. The first research community focuses on multimodal sensing of PD-related biomarkers using noninvasive technologies such as inertial measurement units (IMUs), force/pressure insoles, electromyography (EMG), electroencephalography (EEG), speech and acoustic analysis, and RGB/RGB-D motion capture systems. These studies emphasize data acquisition, feature extraction, and machine learning-based classification for PD screening, diagnosis, and disease progression modeling. In parallel, a second research community has concentrated on robotic intervention and rehabilitation, employing socially assistive robots (SARs), robot-assisted rehabilitation (RAR) systems, and virtual reality (VR)-integrated robotic platforms for improving motor and cognitive function, enhancing social engagement, and supporting caregivers. Despite the complementary goals of these two domains, their methodological and technological integration remains limited, with minimal data-level or decision-level coupling between the two. With the advent of advanced artificial intelligence (AI), including large language models (LLMs), agentic AI systems, a unique opportunity now exists to unify these research streams. We envision a closed-loop sensor-AI-robot framework in which multimodal sensing continuously guides the interaction between the patient, caregiver, humanoid robot (and physician) through AI agents that are powered by a multitude of AI models such as robotic and wearables foundation models, LLM-based reasoning, reinforcement learning, and continual learning. Such closed-loop system enables personalized, explainable, and context-aware intervention, forming the basis for digital twin of the PD patient that can adapt over time to deliver intelligent, patient-centered PD care.

Parkinson's disease (PD) poses challenges in diagnosis and monitoring due to its progressive nature and complex symptoms. This study introduces a novel approach utilizing surface electromyography (sEMG) to objectively assess PD severity, focusing on the biceps brachii muscle. Initial analysis of sEMG data from five PD patients and five healthy controls revealed significant neuromuscular differences. A traditional Support Vector Machine (SVM) model achieved up to 83% accuracy, while enhancements with a Graph Convolutional Network-Support Vector Machine (GCN-SVM) model increased accuracy to 92%. Despite the preliminary nature of these results, the study outlines a detailed experimental methodology for future research with larger cohorts to validate these findings and integrate the approach into clinical practice. The proposed approach holds promise for advancing PD severity assessment and improving patient care in Parkinson's disease management.

The rapid emergence of highly adaptable and reusable artificial intelligence (AI) models is set to revolutionize the medical field, particularly in the diagnosis and management of Parkinson's disease (PD). Currently, there are no effective biomarkers for diagnosing PD, assessing its severity, or tracking its progression. Numerous AI algorithms are now being used for PD diagnosis and treatment, capable of performing various classification tasks based on multimodal and heterogeneous disease symptom data, such as gait, hand movements, and speech patterns of PD patients. They provide expressive feedback, including predicting the potential likelihood of PD, assessing the severity of individual or multiple symptoms, aiding in early detection, and evaluating rehabilitation and treatment effectiveness, thereby demonstrating advanced medical diagnostic capabilities. Therefore, this work provides a surveyed compilation of recent works regarding PD detection and assessment through biometric symptom recognition with a focus on machine learning and deep learning approaches, emphasizing their benefits, and exposing their weaknesses, and their impact in opening up newer research avenues. Additionally, it also presents categorized and characterized descriptions of the datasets, approaches, and architectures employed to tackle associated constraints. Furthermore, the paper explores the potential opportunities and challenges presented by data-driven AI technologies in the diagnosis of PD.

Parkinson's disease (PD) is a progressive neurodegenerative disorder that impacts motor functions and speech characteristics This study focuses on differentiating individuals with Parkinson's disease from healthy controls through the extraction and classification of speech features. Patients were further divided into 2 groups. Med On represents the patient with medication, while Med Off represents the patient without medication. The dataset consisted of patients and healthy individuals who read a predefined text using the H1N Zoom microphone in a suitable recording environment at F{\i}rat University Neurology Department. Speech recordings from PD patients and healthy controls were analyzed, and 19 key features were extracted, including jitter, luminance, zero-crossing rate (ZCR), root mean square (RMS) energy, entropy, skewness, and kurtosis.These features were visualized in graphs and statistically evaluated to identify distinctive patterns in PD patients. Using MATLAB's Classification Learner toolbox, several machine learning classification algorithm models were applied to classify groups and significant accuracy rates were achieved. The accuracy of our 3-layer artificial neural network architecture was also compared with classical machine learning algorithms. This study highlights the potential of noninvasive voice analysis combined with machine learning for early detection and monitoring of PD patients. Future research can improve diagnostic accuracy by optimizing feature selection and exploring advanced classification techniques.

Neural biomarkers that can classify or predict disease are of broad interest to the neurological and psychiatric communities. Such biomarkers can be informative of disease state or treatment efficacy, even before there are changes in symptoms and/or behavior. This work investigates EEG-estimated functional connectivity (FC) as a Parkinson's Disease (PD) biomarker. Specifically, we investigate FC mediated via neural oscillations and consider such activity during the Simons conflict task. This task yields sensory-motor conflict, and one might expect differences in behavior between PD patients and healthy controls (HCs). In addition to considering spatially focused approaches, such as FC, as a biomarker, we also consider temporal biomarkers, which are more sensitive to ongoing changes in neural activity. We find that FC, estimated from delta (1-4Hz) and theta (4-7Hz) oscillations, yields spatial FC patterns significantly better at distinguishing PD from HC than temporal features or behavior. This study reinforces that FC in spectral bands is informative of differences in brain-wide processes and can serve as a biomarker distinguishing normal brain function from that seen in disease.

Parkinson's disease (PD) is a neuro-degenerative disorder that affects movement, speech, and coordination. Timely diagnosis and treatment can improve the quality of life for PD patients. However, access to clinical diagnosis is limited in low and middle income countries (LMICs). Therefore, development of automated screening tools for PD can have a huge social impact, particularly in the public health sector. In this paper, we present PULSAR, a novel method to screen for PD from webcam-recorded videos of the finger-tapping task from the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS). PULSAR is trained and evaluated on data collected from 382 participants (183 self-reported as PD patients). We used an adaptive graph convolutional neural network to dynamically learn the spatio temporal graph edges specific to the finger-tapping task. We enhanced this idea with a multi stream adaptive convolution model to learn features from different modalities of data critical to detect PD, such as relative location of the finger joints, velocity and acceleration of tapping. As the labels of the videos are self-reported, there could be cases of undiagnosed PD in the non-PD labeled samples. We leveraged the idea of Positive Unlabeled (PU) Learning that does not need labeled negative data. Our experiments show clear benefit of modeling the problem in this way. PULSAR achieved 80.95% accuracy in validation set and a mean accuracy of 71.29% (2.49% standard deviation) in independent test, despite being trained with limited amount of data. This is specially promising as labeled data is scarce in health care sector. We hope PULSAR will make PD screening more accessible to everyone. The proposed techniques could be extended for assessment of other movement disorders, such as ataxia, and Huntington's disease.

Eye-tracking is an accessible and non-invasive technology that provides information about a subject's motor and cognitive abilities. As such, it has proven to be a valuable resource in the study of neurodegenerative diseases such as Parkinson's disease. Saccade experiments, in particular, have proven useful in the diagnosis and staging of Parkinson's disease. However, to date, no single eye-movement biomarker has been found to conclusively differentiate patients from healthy controls. In the present work, we investigate the use of state-of-the-art deep learning algorithms to perform Parkinson's disease classification using eye-tracking data from saccade experiments. In contrast to previous work, instead of using hand-crafted features from the saccades, we use raw $\sim1.5\,s$ long fixation intervals recorded during the preparatory phase before each trial. Using these short time series as input we implement two different classification models, InceptionTime and ROCKET. We find that the models are able to learn the classification task and generalize to unseen subjects. InceptionTime achieves $78\%$ accuracy, while ROCKET achieves $88\%$ accuracy. We also employ a novel method for pruning the ROCKET model to improve interpretability and generalizability, achieving an accuracy of $96\%$. Our results suggest that fixation data has low inter-subject variability and potentially carries useful information about brain cognitive and motor conditions, making it suitable for use with machine learning in the discovery of disease-relevant biomarkers.

Abstract--Freezing of gait is a Parkinson's Disease symptom Naghavi et al. discovered that using The best performing model achieves a score of 0.427 One machine learning model uses time-series plantar pressure I. Each Freezing of gait (FOG) is a common Parkinson's disease PD patient is required to complete a 25-meter walking task, (PD) mobility disturbance that episodically inflicts PD patients during which a set of 16 features related to the center of with the inability to step or turn while walking. In advancing pressure coordinates, center of pressure velocities, center of stages of PD, 60% of PD patients could experience FOG pressure accelerations, and ground reaction forces is collected events [1]; each FOG event could last up to a few minutes. A 2-layer LSTM neural network FOG episodes often occur at the initialization of walking (start architecture and a 3-layer LSTM neural network architecture hesitation), turning, or during walking periods, during which show similar performance, achieving 82.1% mean sensitivity PD patients would experience dystonic gait during the "on" and 89.5% mean specificity and 83.4% mean sensitivity and state and hypokinetic gait during the "off" state of FOG [2]. However, plantar pressure insole sensors in to FOG, such as narrow passages, being time pressure, the research are for single use, which means that this detection distractions, dual-tasking, and male sex [3, 4] and actions system cannot generalize to larger scale experiments or reallife that could alleviate FOG, such as emotion, excitement, and detection systems [1].

PD is linked to faster brain aging. Sex is recognized as an important factor in PD, such that males are twice as likely as females to have the disease and have more severe symptoms and a faster progression rate. Despite previous research, there remains a significant gap in understanding the function of sex in the process of brain aging in PD patients. The T1-weighted MRI-driven brain-predicted age difference was computed in a group of 373 PD patients from the PPMI database using a robust brain-age estimation framework that was trained on 949 healthy subjects. Linear regression models were used to investigate the association between brain-PAD and clinical variables in PD, stratified by sex. All female PD patients were used in the correlational analysis while the same number of males were selected based on propensity score matching method considering age, education level, age of symptom onset, and clinical symptom severity. Despite both patient groups being matched for demographics, motor and non-motor symptoms, it was observed that males with Parkinson's disease exhibited a significantly higher mean brain age-delta than their female counterparts . In the propensity score-matched PD male group, brain-PAD was found to be associated with a decline in general cognition, a worse degree of sleep behavior disorder, reduced visuospatial acuity, and caudate atrophy. Conversely, no significant links were observed between these factors and brain-PAD in the PD female group.

Among automatic PD assessment methods, Recently, deep learning (DL)-based methods have particularly deep learning models have gained particular interest. Recently, gained a lot of attention for analyzing PD speech signals the community has explored cross-pathology and crosslanguage [7, 8]. However, a major impediment to developing such models which can improve diagnostic accuracy even robust DL models is the need for accessing lots of training further. However, strict patient data privacy regulations largely data, which is challenging for many institutions. Thus, benefiting prevent institutions from sharing patient speech data with each from data from different external institutions could solve other. In this paper, we employ federated learning (FL) for PD this issue. However, strict patient data privacy regulations in detection using speech signals from 3 real-world language corpora the medical context make this infeasible in most cases in realworld of German, Spanish, and Czech, each from a separate institution.